Literature DB >> 10529597

IL-4 induces eotaxin in human dermal fibroblasts.

M Mochizuki1, J Schröder, E Christophers, S Yamamoto.   

Abstract

A common feature of Th2-mediated skin diseases is selective eosinophil (Eo) infiltration in the affected dermis. However, the mechanisms of selective Eo recruitment are not yet fully understood. Our recent findings indicated that dermal fibroblasts actively participate in the accumulation of Eo in Th2-mediated skin inflammation. Following stimulation with IL-4, dermal fibroblasts produce eotaxin, which is the only biologically active Eo attractant detected in the supernatants. Natural eotaxin is comprised of a mixture of N-terminal-truncated and O-glycosylated variants. The expression of eotaxin mRNA is upregulated within 1 h after stimulation. TNF-alpha markedly enhances eotaxin mRNA expression and release of the protein product from IL-4-stimulated fibroblasts. As mast cells and Th2 cells produce both cytokines, it is probable that Eo recruitment into sites of allergen-induced, Th2-mediated skin reactions is, at least in part, due to IL-4-stimulated induction of eotaxin in dermal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529597     DOI: 10.1159/000053587

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

1.  Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.

Authors:  C Günther; G Wozel; M Meurer; C Pfeiffer
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Low concentrations of cytokines produced by allergen-stimulated peripheral blood mononuclear cells have potent effects on nasal polyp-derived fibroblasts.

Authors:  S Olsson; F Cagnoni; P Dignetti; G Melioli; G W Canonica
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 3.  Basophils Orchestrating Eosinophils' Chemotaxis and Function in Allergic Inflammation.

Authors:  Joseena Iype; Michaela Fux
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.